Pilot Study of Estramustine Added to Radiosurgery and Radiotherapy for Treatment of High Grade Glioma

By Landy Howard   Markoe Arnold   Potter Priscilla   Lasalle Garrett   Marini Angela   Savaraj Niramol   Reis Isildinha   Heros Deborah   Wangpaichitr Medhi   Feun Lynn  

Journal of Neuro-Oncology, Vol. 67, Iss. 1-2, 2004-03 ,pp. : 215-220

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic factors in pediatric high-grade astrocytoma: the importance of accurate pathologic diagnosis

By Hales Russell   Shokek Ori   Burger Peter   Paynter Nina   Chaichana Kaisorn   Quiñones-Hinojosa Alfredo   Jallo George   Cohen Kenneth   Song Danny   Carson Benjamin   Wharam Moody  

Journal of Neuro-Oncology, Vol. 99, Iss. 1, 2010-08 ,pp. : 65-71

Springer Publishing Company

Access to resources Recommend Favorite

The results of hypofractionated radiotherapy in 31 patients with high-grade gliomas

By Sayin Meral   Kaya Bektas   Bakkal Bekir   Altundag Kadri   Altundag Muzaffer  

Medical Oncology, Vol. 24, Iss. 4, 2007-12 ,pp. : 379-383

Humana Press, Inc

Access to resources Recommend Favorite

Temozolomide after Radiotherapy for Newly Diagnosed High-grade Glioma and Unfavorable Low-grade Glioma in Children

By Broniscer Alberto   Chintagumpala Murali   Fouladi Maryam   Krasin Matthew   Kocak Mehmet   Bowers Daniel   Iacono Lisa   Merchant Thomas   Stewart Clinton   Houghton Peter   Kun Larry   Ledet Davonna   Gajjar Amar  

Journal of Neuro-Oncology, Vol. 76, Iss. 3, 2006-02 ,pp. : 313-319

Springer Publishing Company

Access to resources Recommend Favorite

IDH1/2 mutation is a prognostic marker for survival and predicts response to chemotherapy for grade II gliomas concomitantly treated with radiation therapy

By                    

International Journal of Oncology, Vol. 41, Iss. 4, 2012-01 ,pp. : 1325-1336

Spandidos Publications

Access to resources Recommend Favorite